Skip to main content

Loneliness

0
Pipeline Programs
7
Companies
9
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

7 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
Animal-assisted interactionN/A1 trial
Twitter for Hispanic caregiversN/A1 trial
Active Trials
NCT05089201Completed72Est. Jan 2024
NCT03865498Completed966Est. Nov 2023
Temple Therapeutics
Temple TherapeuticsNetherlands - Geleen
2 programs
Community Navigator InterventionN/A1 trial
Need to Be Needed InterventionN/A1 trial
Active Trials
NCT06594029Not Yet Recruiting96Est. Jun 2032
NCT06510439Recruiting120Est. May 2035
Young BioPharma
Young BioPharmaMA - Lowell
1 program
KIND ChallengeN/A1 trial
Active Trials
NCT04398472Completed4,500Est. Jan 2021
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Loneliness InterventionN/A1 trial
Active Trials
NCT04164654Completed221Est. May 2021
Labcorp
LabcorpBURLINGTON, NC
1 program
Phone therapyN/A1 trial
Active Trials
NCT04225845Completed1,120Est. Dec 2023
Forte Biosciences
1 program
Social prescribing in SwedenN/A1 trial
Active Trials
NCT04336553Unknown220Est. Dec 2025
Innovation Pharmaceuticals
1 program
The CONNECT ProgramN/A1 trial
Active Trials
NCT07107906Recruiting128Est. Dec 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Innovation PharmaceuticalsThe CONNECT Program
Temple TherapeuticsNeed to Be Needed Intervention
Temple TherapeuticsCommunity Navigator Intervention
Forte BiosciencesSocial prescribing in Sweden
Human BioSciencesTwitter for Hispanic caregivers
Human BioSciencesAnimal-assisted interaction
LabcorpPhone therapy
Young BioPharmaKIND Challenge
Oregon TherapeuticsLoneliness Intervention

Clinical Trials (9)

Total enrollment: 7,443 patients across 9 trials

Evaluating and Implementing The CONNECT Program - a Group-Based Telehealth Intervention to Reduce Social Isolation, Loneliness, and Mental Health Symptoms in Adults Ages 55+, Compared to Routine Community-Based Programming

Start: Sep 2025Est. completion: Dec 2026128 patients
N/ARecruiting
NCT06510439Temple TherapeuticsNeed to Be Needed Intervention

Need to be Needed (N2BN) Intervention

Start: Oct 2024Est. completion: May 2035120 patients
N/ARecruiting
NCT06594029Temple TherapeuticsCommunity Navigator Intervention

Community Navigators

Start: Sep 2024Est. completion: Jun 203296 patients
N/ANot Yet Recruiting
NCT04336553Forte BiosciencesSocial prescribing in Sweden

Social Prescribing in Sweden (SPiS)

Start: May 2023Est. completion: Dec 2025220 patients
N/AUnknown
NCT03865498Human BioSciencesTwitter for Hispanic caregivers

Twitter Based Social Support for Hispanic and Black Dementia Caregivers

Start: Jan 2022Est. completion: Nov 2023966 patients
N/ACompleted
NCT05089201Human BioSciencesAnimal-assisted interaction

A Pilot Study to Examine the Impact of a Therapy Dog Intervention on Loneliness and Related Health Outcomes in Vulnerable Populations

Start: Nov 2021Est. completion: Jan 202472 patients
N/ACompleted
NCT04225845LabcorpPhone therapy

The Economic Consequences of Loneliness Among the Elderly

Start: Nov 2020Est. completion: Dec 20231,120 patients
N/ACompleted

Evaluation of the Nextdoor KIND Challenge

Start: Jul 2020Est. completion: Jan 20214,500 patients
N/ACompleted
NCT04164654Oregon TherapeuticsLoneliness Intervention

A Mobile App to Address Student Loneliness

Start: Sep 2019Est. completion: May 2021221 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 actively recruiting trials targeting 7,443 patients
7 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.